New research from the FLASH registry (ClinicalTrials.gov identifier: NCT03761173) shines a light on the effectiveness of large-bore mechanical thrombectomy in managing high-risk pulmonary embolism.

The use of mechanical thrombectomy (MT) was associated with reduced major adverse events in the short term and improved quality of life in the long term for pulmonary embolism (PE) patients with ...

Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.

WASHINGTON, DC — Large-bore mechanical thrombectomy is superior to catheter-directed thrombolysis for pulmonary embolism, according to a randomized trial comparing the two interventions. Although ...

The FDA announced 510(k) clearance for Inari Medical’s FlowTriever device for the treatment of pulmonary embolism (“PE”). According to Inari, the FlowTriever system is the first thrombectomy device ...

HENDERSONVILLE, Tenn. (WSMV) - TriStar Hendersonville Medical Center announced the hospital’s first successful pulmonary thrombectomy. A pulmonary thrombectomy is a procedure that removes blood clots ...

June Hoffman's shortness of breath snuck up on her. It started in the morning, hardly noticeable as she got dressed for a routine visit to her rheumatologists office. But by the time she reached the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Large-bore mechanical thrombectomy for pulmonary ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHOENIX -- ...

NEW ORLEANS -- Large-bore mechanical thrombectomy for high-risk pulmonary embolism (PE) was associated with fewer major adverse outcomes than other approaches, the FLAME study showed. Clot removal ...

Six month outcomes from the FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH) registry were presented today as late-breaking clinical research at the Society for ...

CAMPBELL, Calif., September 17, 2025--(BUSINESS WIRE)--Imperative Care, Inc. today announced positive efficacy and safety results from the pivotal SYMPHONY-PE Trial (NCT06062329) evaluating the ...